Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

John Corboy

Concepts (369)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
47
2024
380
8.350
Why?
Multiple Sclerosis, Relapsing-Remitting
14
2024
69
3.130
Why?
Neurology
10
2018
85
2.510
Why?
Immunosuppressive Agents
10
2024
666
1.820
Why?
Immunologic Factors
11
2020
219
1.720
Why?
Neuromyelitis Optica
4
2023
114
1.260
Why?
Natalizumab
11
2021
46
1.020
Why?
Recurrence
7
2024
949
0.800
Why?
Diagnostic Errors
2
2017
151
0.780
Why?
Internship and Residency
5
2011
949
0.760
Why?
Drug Substitution
2
2019
46
0.700
Why?
Fingolimod Hydrochloride
5
2020
30
0.690
Why?
Rituximab
4
2020
149
0.660
Why?
Brain
14
2021
2382
0.650
Why?
Data Collection
4
2011
636
0.640
Why?
Dementia, Vascular
3
2009
17
0.630
Why?
Drug Monitoring
1
2019
184
0.610
Why?
Early Medical Intervention
1
2017
51
0.570
Why?
Medication Adherence
2
2019
536
0.570
Why?
Early Diagnosis
2
2017
221
0.560
Why?
Glatiramer Acetate
6
2019
20
0.540
Why?
Physicians
4
2016
774
0.540
Why?
Calcinosis
2
2009
244
0.510
Why?
Antibodies, Monoclonal, Humanized
8
2023
664
0.510
Why?
Postural Balance
3
2018
182
0.510
Why?
Humans
79
2024
115899
0.490
Why?
Magnetic Resonance Imaging
23
2023
3086
0.470
Why?
Fatigue
3
2018
295
0.430
Why?
Dimethyl Fumarate
3
2020
10
0.400
Why?
Immunoglobulin G
4
2023
782
0.390
Why?
Practice Guidelines as Topic
1
2018
1403
0.360
Why?
Multiple Sclerosis, Chronic Progressive
3
2020
25
0.360
Why?
Withholding Treatment
2
2021
69
0.350
Why?
Middle Aged
37
2021
27082
0.340
Why?
Psychiatry
2
2009
155
0.330
Why?
Adult
41
2023
30816
0.310
Why?
Cysts
1
2009
94
0.310
Why?
Demyelinating Diseases
4
2019
76
0.310
Why?
Education, Medical
1
2011
224
0.310
Why?
Certification
1
2008
90
0.300
Why?
Autoantibodies
3
2023
1362
0.300
Why?
Clinical Trials as Topic
3
2016
945
0.290
Why?
Education
2
2007
99
0.280
Why?
Central Nervous System Cysts
1
2006
12
0.280
Why?
Cerebral Arteries
1
2006
55
0.270
Why?
Myelin-Oligodendrocyte Glycoprotein
2
2023
43
0.270
Why?
Single-Blind Method
3
2023
256
0.270
Why?
Cerebrovascular Disorders
1
2006
82
0.270
Why?
Societies, Medical
4
2019
690
0.260
Why?
Treatment Outcome
12
2023
9165
0.260
Why?
HIV Long Terminal Repeat
2
1997
7
0.260
Why?
DNA, Viral
2
1998
351
0.260
Why?
Female
46
2023
60080
0.260
Why?
Databases, Factual
3
2016
1149
0.250
Why?
Double-Blind Method
4
2023
1665
0.240
Why?
Male
36
2023
56125
0.240
Why?
Drug Industry
2
2016
104
0.240
Why?
Conflict of Interest
2
2016
120
0.230
Why?
Encephalomyelitis, Autoimmune, Experimental
1
2023
50
0.220
Why?
Quality of Health Care
2
2017
578
0.200
Why?
B-Lymphocytes
5
2023
770
0.200
Why?
Mental Disorders
2
2007
908
0.200
Why?
Brain Neoplasms
4
2016
979
0.200
Why?
Lymphoma
2
2005
177
0.200
Why?
Interferon beta-1a
2
2019
12
0.190
Why?
Central Nervous System Neoplasms
2
2005
125
0.190
Why?
Neuroimaging
1
2023
251
0.190
Why?
Education, Medical, Continuing
2
2015
119
0.190
Why?
Lymphopenia
1
2020
49
0.180
Why?
Disease Progression
4
2021
2424
0.180
Why?
Agammaglobulinemia
1
2020
31
0.180
Why?
Referral and Consultation
1
2005
647
0.180
Why?
Interferon-gamma
1
2023
731
0.180
Why?
Neutropenia
1
2020
127
0.170
Why?
Serum Sickness
1
2019
7
0.170
Why?
Indans
1
2019
9
0.170
Why?
Oxadiazoles
1
2019
32
0.170
Why?
Diagnosis, Differential
4
2023
1358
0.170
Why?
Adjuvants, Immunologic
3
2015
205
0.160
Why?
Educational Measurement
3
2015
264
0.160
Why?
Lymphoma, AIDS-Related
1
1998
13
0.150
Why?
Salvage Therapy
1
2019
128
0.150
Why?
Physician-Patient Relations
2
2016
466
0.150
Why?
Hematopoietic Stem Cell Transplantation
2
2019
522
0.150
Why?
Eye Movements
1
2018
53
0.150
Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
242
0.150
Why?
Herpesvirus 8, Human
1
1998
63
0.150
Why?
AIDS Dementia Complex
1
1997
50
0.150
Why?
Diffuse Cerebral Sclerosis of Schilder
1
2017
4
0.150
Why?
Central Nervous System
2
2005
239
0.150
Why?
Patient Selection
2
2015
656
0.150
Why?
Sarcoma, Kaposi
1
1998
69
0.150
Why?
Herpesvirus 4, Human
1
2018
123
0.150
Why?
HIV Seropositivity
1
1998
110
0.140
Why?
Young Adult
6
2023
10516
0.140
Why?
Neurologists
1
2016
18
0.140
Why?
Herpesviridae Infections
1
1998
138
0.140
Why?
Costs and Cost Analysis
1
2017
200
0.140
Why?
Cost-Benefit Analysis
2
2016
545
0.140
Why?
Aged
8
2023
19298
0.130
Why?
Estriol
1
2015
5
0.130
Why?
T-Lymphocytes
1
2023
1754
0.130
Why?
Dizziness
2
2018
70
0.130
Why?
Verbal Learning
2
2013
63
0.130
Why?
Corpus Callosum
2
2006
57
0.130
Why?
Follow-Up Studies
6
2020
4446
0.130
Why?
Diffusion Magnetic Resonance Imaging
2
2006
86
0.130
Why?
Trust
1
2016
108
0.120
Why?
Retrospective Studies
9
2020
12616
0.120
Why?
Ethics, Medical
1
2015
70
0.120
Why?
Mesenchymal Stem Cell Transplantation
1
2014
37
0.120
Why?
Exercise Therapy
1
2018
353
0.120
Why?
Insurance, Health
1
2016
247
0.110
Why?
Medication Reconciliation
1
2013
25
0.110
Why?
CD40 Antigens
1
2014
80
0.110
Why?
T-Lymphocytes, Helper-Inducer
1
2014
129
0.110
Why?
JC Virus
1
2013
23
0.110
Why?
Anti-Inflammatory Agents
2
2006
447
0.110
Why?
Population Surveillance
1
2016
397
0.110
Why?
Sensation Disorders
1
2012
30
0.110
Why?
Glioma
1
2016
296
0.100
Why?
Memory Disorders
1
2013
155
0.100
Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
18
0.100
Why?
Immunoglobulin Heavy Chains
3
2007
72
0.100
Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
38
0.100
Why?
Lymphoma, T-Cell, Peripheral
1
2012
15
0.100
Why?
Optic Nerve
2
2005
65
0.100
Why?
T-Lymphocyte Subsets
1
2014
382
0.100
Why?
Gadolinium
4
2018
78
0.090
Why?
Quality of Life
3
2021
2392
0.090
Why?
Learning
1
2015
360
0.090
Why?
Self-Assessment
1
2011
63
0.090
Why?
Academies and Institutes
1
2011
44
0.090
Why?
Biomarkers
3
2014
3473
0.090
Why?
Nervous System Diseases
1
2013
253
0.090
Why?
Nerve Regeneration
1
2010
53
0.090
Why?
Fatal Outcome
3
2006
286
0.090
Why?
Diagnostic Tests, Routine
1
2011
89
0.090
Why?
Antigens, CD19
3
2007
97
0.090
Why?
Leukocytosis
1
2010
35
0.090
Why?
Exercise Test
1
2012
541
0.090
Why?
Severity of Illness Index
3
2014
2598
0.090
Why?
Cranial Nerve Neoplasms
1
1989
6
0.090
Why?
Hemangioma, Cavernous
1
1989
15
0.090
Why?
Optic Chiasm
1
1989
18
0.090
Why?
Central Nervous System Infections
1
2010
36
0.090
Why?
Disease Management
1
2013
562
0.080
Why?
United States
7
2019
12340
0.080
Why?
Guidelines as Topic
1
2011
246
0.080
Why?
Spinal Cord
3
2023
351
0.080
Why?
Neuroprotective Agents
1
2009
105
0.080
Why?
Physical Therapy Modalities
1
2011
270
0.080
Why?
Practice Patterns, Physicians'
1
2016
1177
0.080
Why?
Workload
1
2009
132
0.080
Why?
Hospital-Physician Relations
1
2007
2
0.070
Why?
Antibodies, Monoclonal
2
2011
1262
0.070
Why?
Neuropsychological Tests
2
2013
932
0.070
Why?
Immunoglobulin Variable Region
2
2004
72
0.070
Why?
HIV-1
1
1992
769
0.070
Why?
Headache Disorders
1
2006
12
0.070
Why?
Vasculitis, Central Nervous System
1
2006
17
0.070
Why?
Nerve Fibers, Myelinated
1
2006
41
0.070
Why?
Huntington Disease
1
2007
38
0.070
Why?
Medical Records
1
2007
157
0.070
Why?
Glial Fibrillary Acidic Protein
1
2006
82
0.070
Why?
Syndrome
2
2023
339
0.070
Why?
International Classification of Diseases
1
2007
118
0.070
Why?
Methylprednisolone
1
2006
83
0.070
Why?
Contrast Media
3
2018
366
0.070
Why?
Antibody Formation
1
2007
273
0.070
Why?
Intracranial Hemorrhages
1
2006
76
0.070
Why?
Aquaporin 4
1
2006
86
0.070
Why?
Fellowships and Scholarships
1
2009
240
0.070
Why?
Herpes Zoster
1
2010
333
0.070
Why?
Canada
2
2019
337
0.070
Why?
Surveys and Questionnaires
4
2016
4671
0.060
Why?
DNA Mutational Analysis
1
2006
378
0.060
Why?
RNA, Messenger
1
1992
2581
0.060
Why?
Health Care Surveys
1
2007
540
0.060
Why?
Patient Compliance
1
2009
524
0.060
Why?
Erythrocytes
1
2010
590
0.060
Why?
Cognition Disorders
1
2009
479
0.060
Why?
Teaching
1
2007
226
0.060
Why?
Affect
1
2007
244
0.060
Why?
Neurologic Examination
1
2005
117
0.060
Why?
Analysis of Variance
3
2015
1226
0.060
Why?
Program Evaluation
1
2009
839
0.060
Why?
Central Nervous System Diseases
1
2005
62
0.060
Why?
Neutrophils
1
2010
1170
0.060
Why?
Simvastatin
1
2004
60
0.060
Why?
Faculty, Medical
1
2006
233
0.060
Why?
Ophthalmoplegia
1
2003
8
0.060
Why?
Proteoglycans
1
2004
108
0.060
Why?
Diagnostic Techniques, Ophthalmological
1
2003
36
0.060
Why?
Adolescent
7
2021
17955
0.050
Why?
B-Lymphocyte Subsets
1
2003
67
0.050
Why?
Cyclophosphamide
1
2003
218
0.050
Why?
Anticoagulants
1
2006
545
0.050
Why?
Radiography
1
2005
827
0.050
Why?
Cross-Sectional Studies
1
2012
4449
0.050
Why?
Academic Medical Centers
1
2005
415
0.050
Why?
Students, Medical
1
2006
280
0.050
Why?
Dementia
1
2005
185
0.050
Why?
Membrane Glycoproteins
1
2004
429
0.050
Why?
Infusions, Intravenous
1
2023
374
0.050
Why?
Lymphoma, B-Cell
2
2005
85
0.050
Why?
Patient Outcome Assessment
1
2023
123
0.050
Why?
Clinical Competence
1
2008
918
0.050
Why?
Peptides
3
2013
862
0.050
Why?
Time Factors
4
2018
6186
0.050
Why?
Pain
1
2007
713
0.050
Why?
Schools, Medical
1
2002
125
0.050
Why?
Disability Evaluation
2
2014
273
0.050
Why?
Molecular Sequence Data
3
2004
2793
0.050
Why?
Antibodies, Antinuclear
1
2001
60
0.050
Why?
Atrophy
1
2021
154
0.050
Why?
Consensus
1
2023
533
0.050
Why?
Child
5
2016
18555
0.050
Why?
Mobility Limitation
1
2020
60
0.040
Why?
Antibodies, Viral
1
2023
520
0.040
Why?
Interferon-beta
2
2011
80
0.040
Why?
Lymphocyte Activation
1
2003
1056
0.040
Why?
Lipids
1
2023
589
0.040
Why?
Maintenance Chemotherapy
1
2019
22
0.040
Why?
Induction Chemotherapy
1
2019
56
0.040
Why?
Cerebral Infarction
1
1998
39
0.040
Why?
Cell Separation
2
2014
293
0.040
Why?
Transplantation, Autologous
1
2019
176
0.040
Why?
HIV Seronegativity
1
1998
24
0.040
Why?
Genes, myc
1
1998
47
0.040
Why?
Astrocytoma
1
1998
108
0.040
Why?
Risk Assessment
1
2006
3004
0.040
Why?
In Situ Hybridization
1
2018
298
0.040
Why?
Gene Library
1
1997
116
0.040
Why?
Gene Rearrangement
1
1998
135
0.040
Why?
Breast Neoplasms
1
2008
1870
0.040
Why?
Real-Time Polymerase Chain Reaction
1
2018
319
0.040
Why?
Syndecan-1
2
2007
28
0.030
Why?
Flow Cytometry
2
2014
1058
0.030
Why?
Mutation
1
2006
3369
0.030
Why?
Viral Load
1
2018
406
0.030
Why?
Drug Administration Schedule
1
2018
724
0.030
Why?
Colorado
1
2005
4122
0.030
Why?
Child, Preschool
3
2016
9175
0.030
Why?
Polymerase Chain Reaction
1
1998
1001
0.030
Why?
Survival Analysis
1
2018
1221
0.030
Why?
Sequence Analysis, DNA
1
1997
733
0.030
Why?
Health Knowledge, Attitudes, Practice
2
2016
1193
0.030
Why?
Patient Care Team
1
2019
521
0.030
Why?
Incidence
1
2020
2333
0.030
Why?
Base Sequence
1
1997
2120
0.030
Why?
Congresses as Topic
1
2015
200
0.030
Why?
Propylene Glycols
1
2013
26
0.030
Why?
Ocular Physiological Phenomena
1
1992
11
0.030
Why?
Sphingosine
1
2013
32
0.030
Why?
HLA-DR Antigens
1
2014
220
0.030
Why?
beta-Galactosidase
1
1992
63
0.030
Why?
Quality-Adjusted Life Years
1
2013
103
0.030
Why?
Drug Therapy, Combination
1
2015
961
0.030
Why?
Markov Chains
1
2013
115
0.030
Why?
Mice
2
2023
15073
0.030
Why?
Mice, Inbred DBA
1
1992
173
0.030
Why?
Animals
3
2023
32121
0.030
Why?
Haplotypes
1
2014
472
0.030
Why?
Mental Recall
1
2013
173
0.030
Why?
Comparative Effectiveness Research
1
2013
130
0.030
Why?
Organ Specificity
1
1992
273
0.030
Why?
Reference Values
1
2013
745
0.030
Why?
CD3 Complex
1
2012
92
0.030
Why?
Depression
2
2011
1149
0.030
Why?
Intestine, Small
1
1992
125
0.020
Why?
Ki-67 Antigen
1
2012
104
0.020
Why?
Thymus Gland
1
1992
297
0.020
Why?
Mitoxantrone
1
2011
12
0.020
Why?
Patient Participation
1
2015
362
0.020
Why?
Hematologic Tests
1
2011
22
0.020
Why?
Muscle Stretching Exercises
1
2011
17
0.020
Why?
Clinical Laboratory Techniques
1
2011
86
0.020
Why?
Randomized Controlled Trials as Topic
2
2006
1216
0.020
Why?
Aged, 80 and over
2
2016
6438
0.020
Why?
Physical Endurance
1
2011
223
0.020
Why?
Recombinant Fusion Proteins
1
1992
616
0.020
Why?
Amino Acid Sequence
2
2004
2000
0.020
Why?
Prevalence
1
2016
2271
0.020
Why?
Acyclovir
1
2010
100
0.020
Why?
Spinal Cord Neoplasms
1
1989
40
0.020
Why?
Respiratory Function Tests
1
2011
541
0.020
Why?
Cell Count
1
2010
304
0.020
Why?
History, 19th Century
1
2009
57
0.020
Why?
Pilot Projects
2
2004
1374
0.020
Why?
Neoplasms, Multiple Primary
1
1989
52
0.020
Why?
Injections
1
2009
163
0.020
Why?
History, 21st Century
1
2009
164
0.020
Why?
Autoimmunity
1
2014
823
0.020
Why?
Electrocardiography
1
2011
554
0.020
Why?
History, 20th Century
1
2009
276
0.020
Why?
Mice, Transgenic
1
1992
1970
0.020
Why?
Age of Onset
1
2009
455
0.020
Why?
Gene Expression
1
1992
1442
0.020
Why?
Memory
1
2009
211
0.020
Why?
Walking
1
2011
426
0.020
Why?
Health
1
2007
74
0.020
Why?
CD8-Positive T-Lymphocytes
1
2012
686
0.020
Why?
Prognosis
2
2006
3342
0.020
Why?
Association Learning
1
2007
60
0.020
Why?
Cerebral Ventricles
1
2006
47
0.020
Why?
Motor Skills
1
2007
80
0.020
Why?
Phenotype
1
2014
2858
0.020
Why?
Hospitalization
1
2015
1761
0.020
Why?
Herpesvirus 3, Human
1
2010
381
0.020
Why?
Immunologic Memory
1
2007
312
0.020
Why?
Hypothalamus
1
2006
150
0.020
Why?
Genetics
1
2005
28
0.020
Why?
Social Support
1
2009
541
0.020
Why?
Neurosciences
1
2005
20
0.020
Why?
Models, Theoretical
1
2009
527
0.020
Why?
Image Interpretation, Computer-Assisted
1
2006
219
0.020
Why?
Clinical Protocols
1
2006
233
0.020
Why?
Syndecans
1
2004
5
0.020
Why?
Internet
1
2009
596
0.020
Why?
Anisotropy
1
2004
62
0.020
Why?
Antiviral Agents
1
2010
648
0.010
Why?
Risk Factors
2
2008
8714
0.010
Why?
Plasma Cells
1
2004
57
0.010
Why?
Immune System
1
2005
173
0.010
Why?
Gene Rearrangement, B-Lymphocyte, Light Chain
1
2003
4
0.010
Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2003
12
0.010
Why?
Videotape Recording
1
2003
30
0.010
Why?
Infrared Rays
1
2003
21
0.010
Why?
Lymphoma, Large B-Cell, Diffuse
1
2005
93
0.010
Why?
Meningitis, Viral
1
2003
21
0.010
Why?
Feasibility Studies
1
2006
750
0.010
Why?
Saccades
1
2003
35
0.010
Why?
Antilymphocyte Serum
1
2003
66
0.010
Why?
Oligoclonal Bands
1
2003
21
0.010
Why?
Astrocytes
1
2005
165
0.010
Why?
Mice, Inbred C57BL
1
1992
4767
0.010
Why?
Antigens, CD34
1
2003
97
0.010
Why?
Microglia
1
2005
205
0.010
Why?
Clone Cells
1
2003
247
0.010
Why?
Whole-Body Irradiation
1
2003
72
0.010
Why?
Receptors, Antigen, B-Cell
1
2003
102
0.010
Why?
Immunoglobulins
1
2003
148
0.010
Why?
Observer Variation
1
2003
299
0.010
Why?
Longitudinal Studies
1
2009
2437
0.010
Why?
Tomography, X-Ray Computed
1
2012
2408
0.010
Why?
Sex Characteristics
1
2007
644
0.010
Why?
Age Factors
1
2009
2915
0.010
Why?
Administration, Oral
1
2004
731
0.010
Why?
Infant
1
2015
8002
0.010
Why?
Urinary Tract Infections
1
2003
136
0.010
Why?
Biopsy
1
2005
1056
0.010
Why?
Cohort Studies
1
2011
4961
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
934
0.010
Why?
Immunoglobulin kappa-Chains
1
2001
18
0.010
Why?
Predictive Value of Tests
1
2006
1817
0.010
Why?
Cytomegalovirus Infections
1
2003
180
0.010
Why?
Acute Disease
1
2003
917
0.010
Why?
Immunoglobulin Fab Fragments
1
2001
69
0.010
Why?
Combined Modality Therapy
1
2003
1128
0.010
Why?
Research
1
2003
398
0.010
Why?
Lung
1
1992
3685
0.010
Why?
Survival Rate
1
2003
1653
0.010
Why?
Sensitivity and Specificity
1
2003
1728
0.010
Why?
Arachnoid
1
1998
9
0.010
Why?
Models, Biological
1
2005
1647
0.010
Why?
Case-Control Studies
1
2004
3056
0.010
Why?
Aging
1
2007
1641
0.010
Why?
Reproducibility of Results
1
2003
2814
0.010
Why?
Corboy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)